Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T C Merigan

Showing results (101-110 of 366) with videos related to

Pageof 37
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1995
Characterization of HLA-A 0201-restricted cytotoxic T cell epitopes in conserved regions of the HIV type 1 gp160 proteinM Dupuis, S K Kundu, T C Merigan
The Journal of General Virology|February 1, 1980
Type I and type II interferons: differential antiviral actions in transformed cellsM F Bourgeade, C Chany, T C Merigan
Immunology|April 1, 1979
In vitro production and cellular origin of murine type II interferonG Sonnenfeld, A D Mandel, T C Merigan
Journal of Medical Virology|January 1, 1984
DNA of 21 clinical cytomegalovirus strains detected by hybridization to cloned DNA fragments of laboratory strain AD-169S W Chou, L Roark, T C Merigan
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1979
Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferonW E Seaman, T C Merigan, N Talal
Antimicrobial Agents and Chemotherapy|August 3, 1999
Hydroxyurea enhances the activities of didanosine, 9-[2-(phosphonylmethoxy)ethyl]adenine, and 9-[2-(phosphonylmethoxy)propyl]adenine against drug-susceptible and drug-resistant human immunodeficiency virus isolatesS Palmer, R W Shafer, T C Merigan
The Journal of Infectious Diseases|October 1, 1994
Long-term effects of interleukin-2 on CD4 cell counts in human immunodeficiency virus-infected patientsR V Ramachandran, D Katzenstein, T C Merigan
Lancet (London, England)|June 27, 1981
Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infectionsS Chou, J G Gallagher, T C Merigan
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virusD H Schwartz, G Skowron, T C Merigan
Cellular Immunology|December 1, 1977
The immunosuppressive effect of type II mouse interferon preparations on antibody productionG Sonnenfeld, A D Mandel, T C Merigan
Pageof 37

Showing results (101-110 of 366) with videos related to

Sort By:
Pageof 37
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1995
Characterization of HLA-A 0201-restricted cytotoxic T cell epitopes in conserved regions of the HIV type 1 gp160 proteinM Dupuis, S K Kundu, T C Merigan
The Journal of General Virology|February 1, 1980
Type I and type II interferons: differential antiviral actions in transformed cellsM F Bourgeade, C Chany, T C Merigan
Immunology|April 1, 1979
In vitro production and cellular origin of murine type II interferonG Sonnenfeld, A D Mandel, T C Merigan
Journal of Medical Virology|January 1, 1984
DNA of 21 clinical cytomegalovirus strains detected by hybridization to cloned DNA fragments of laboratory strain AD-169S W Chou, L Roark, T C Merigan
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1979
Natural killing in estrogen-treated mice responds poorly to poly I.C despite normal stimulation of circulating interferonW E Seaman, T C Merigan, N Talal
Antimicrobial Agents and Chemotherapy|August 3, 1999
Hydroxyurea enhances the activities of didanosine, 9-[2-(phosphonylmethoxy)ethyl]adenine, and 9-[2-(phosphonylmethoxy)propyl]adenine against drug-susceptible and drug-resistant human immunodeficiency virus isolatesS Palmer, R W Shafer, T C Merigan
The Journal of Infectious Diseases|October 1, 1994
Long-term effects of interleukin-2 on CD4 cell counts in human immunodeficiency virus-infected patientsR V Ramachandran, D Katzenstein, T C Merigan
Lancet (London, England)|June 27, 1981
Controlled clinical trial of intravenous acyclovir in heart-transplant patients with mucocutaneous herpes simplex infectionsS Chou, J G Gallagher, T C Merigan
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Safety and effects of interleukin-2 plus zidovudine in asymptomatic individuals infected with human immunodeficiency virusD H Schwartz, G Skowron, T C Merigan
Cellular Immunology|December 1, 1977
The immunosuppressive effect of type II mouse interferon preparations on antibody productionG Sonnenfeld, A D Mandel, T C Merigan
Pageof 37